Laddawan Lalert

Dr. Laddawan Lalert


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
LLLaddawan Lalert
Laddawan Lalert
HKHathairat Kruevaisayawan
Hathairat Kruevaisayawan
PAPatcharada Amatyakul
Patcharada Amatyakul
KIKornkanok Ingkaninan
Kornkanok Ingkaninan
OKOnrawee Khongsombat
Onrawee Khongsombat

30 July 2019 in Neurotoxicity Research
Verified
Journal Article
Closed access
PDF file
LLLaddawan Lalert
Laddawan Lalert
WJWilawan Ji-Au
Wilawan Ji-Au
SSSirinapa Srikam
Sirinapa Srikam
TCTipthanan Chotipinit
Tipthanan Chotipinit
SSSompol Sanguanrungsirikul
Sompol Sanguanrungsirikul
SGSupang Maneesri-Le Grand
Supang Maneesri-Le Grand

13 July 2022 in Addiction Biology
Verified
Journal Article
Open access
DSDiana Sketriene
Diana Sketriene
DBDamien Battista
Damien Battista
LLLaddawan Lalert
Laddawan Lalert
NKNatcharee Kraiwattanapirom
Natcharee Kraiwattanapirom
HTHan Ngoc Thai
Han Ngoc Thai
RBRobyn Brown
Robyn Brown
Chronic overeating is a core feature of diet‐induced obesity. There is increasing evidence that in vulnerable individuals, such overeating could become compulsive, resembling an addictive disorder. The transition to compulsive substance use has been linked with changes at glutamatergic synapses in the nucleus accumbens. In this study, we investigated a potential link between such glutamatergic dysregulation and compulsive‐like eating using a rat model of diet‐induced obesity. A conditioned suppression task demonstrated that diet‐induced obese rats display eating despite negative consequences, as their consumption was insensitive to an aversive cue. Moreover, nucleus accumbens expression of GluA1 and xCT proteins was upregulated in diet‐induced obese animals. Lastly, both a computed ‘addiction score’ (based on performance across three criteria) and weight gain were positively correlated with changes in GluA1 and xCT expression in the nucleus accumbens. These data demonstrate that the propensity for diet‐induced obesity is associated with compulsive‐like eating of highly palatable food and is accompanied by ‘addiction‐like’ glutamatergic dysregulation in the nucleus accumbens, thus providing neurobiological evidence of addiction‐like pathology in this model of obesity.

13 February 2023 in Scientia Pharmaceutica
Verified
Journal Article
Open access
PDF file
LLLaddawan Lalert
Laddawan Lalert
NTNutnicha Tantarungsee
Nutnicha Tantarungsee
TCTipthanan Chotipinit
Tipthanan Chotipinit
WJWilawan Ji-Au
Wilawan Ji-Au
ASAnan Srikiatkhachorn
Anan Srikiatkhachorn
SGSupang Maneesri-Le Grand
Supang Maneesri-Le Grand
Paracetamol (acetaminophen, APAP) is known as a safe pain reliever; however, its negative effects on the central nervous system have gradually been reported. We examined alterations in learning and memory, and brain-derived neurotrophic factor (BDNF) expression in the frontal cortex and hippocampus at different durations of APAP treatment in rats. Novel object recognition (NOR) and Morris water maze (MWM) paradigms were used to assess learning and memory in rats fed with 200 mg/kg APAP at single-dose, 15-day or 30-day treatments. BDNF expression was evaluated through immunohistochemistry and Western blotting. The single-dose APAP treatment did not alter the NOR performance. However, deficits in the NOR and MWM capacities were detected in the rats with longer durations of APAP treatment. An analysis of BDNF expression revealed no significant change in BDNF expression in the single-dose APAP treatment, while rats given APAP for extended periods as treatment showed a significant decrement in this protein in the frontal cortex and hippocampus. Short-term APAP treatment has no effect on learning and memory, or BDNF expression; however, long-term APAP exposure causes cognitive impairment. The diminishment of the BDNF level in the frontal cortex and hippocampus due to the long period of treatment with APAP may at least in part be involved in altered learning and memory in rats.

23 January 2022 in Scientifica
Verified
Journal Article
Open access
PDF file
SHSoontaraporn Huntula
Soontaraporn Huntula
LLLaddawan Lalert
Laddawan Lalert
CPChuchard Punsawad
Chuchard Punsawad
Aging is generally known to be associated with dynamic biological changes, physiological dysfunction, and environmental and psychological decline. Several studies have suggested that aging is associated with increased inflammatory cytokines, causing several diseases. However, the effect of exercise on aging has been less delineated, and the relationships between cytokine activation, aging, and exercise also need further study. Here, we discuss some ideas about the effect of exercise on aging-induced exaggerated cytokine responses and discuss the possible roles of the aging-induced exaggerated cytokine response following exercise. Evidence from these findings suggests that exercise is a beneficially applicable model to use in studies on the mechanisms underlying the age-associated gradated cytokine response, and these results may provide guidelines for health professionals with diverse backgrounds.

15 October 2022 in Heliyon
Verified
Journal Article
Open access
LLLaddawan Lalert
Laddawan Lalert
SLSupang Maneesri Le-Grand
Supang Maneesri Le-Grand
TTTachpon Techarang
Tachpon Techarang
SHSoontaraporn Huntula
Soontaraporn Huntula
CPChuchard Punsawad
Chuchard Punsawad
Aging is closely associated to several deleterious conditions and cognitive impairment. Administration of low-dose paracetamol (APAP) has previously been reported to improve cognitive performance in both human and animal studies. However, the altered cognitive effects of low-dose APAP treatment in the aging brain have not been elucidated. The purpose of this study was to determine whether low-dose APAP treatment improves cognitive dysfunction in a d-galactose (d-gal)-induced aging model. APAP (15 and 50 mg/kg p.o.) and vitamin E (Vit E 100 mg/kg p.o.) were administered once daily to d-gal-injected mice (200 mg/kg s.c.) for 6 weeks. The elevated plus maze (EPM), open field, novel object recognition (NOR), and Morris water maze (MWM) tests, respectively, were used to measure altered neurobehavioral functions, including anxiety-like behavior and exploratory locomotor activity, as well as learning and memory performance. The gene transcription of brain-derived neurotrophic factor (BDNF)/tropomyosin receptor kinase B (TrkB) signaling in brain tissues was evaluated by real-time polymerase chain reaction. Compared to the control, d-gal significantly decreased exploratory locomotor activity and NOR and MWM performance but did not significantly change the activity in the EPM test. However, APAP50 and Vit E significantly reversed the effects of d-gal injection on exploratory locomotor activity. In addition, low-dose APAP (15 and 50 mg/kg) and Vit E significantly improved the reduction in NOR and MWM performance induced by d-gal. Real-time polymerase chain reaction analysis revealed that the mRNA expression of BDNF, neurotrophic tyrosine receptor kinase (NTRK), which is the gene coding TrkB receptor, and cAMP response element-binding protein (CREB) was significantly decreased in the frontal cortex and hippocampus of the d-gal mice. However, APAP50 and Vit E significantly increased BDNF and NTRK mRNA expression in both the frontal cortex and the hippocampus. A lower dose of APAP (15 mg/kg) significantly elevated the mRNA expression of NTRK, but only in the hippocampus. Moreover, APAP50 significantly increased CREB mRNA expression in the frontal cortex and hippocampus. Low-dose APAP treatment has a neuroprotective effect on cognitive dysfunction in the d-gal aging model, and the underlying molecular mechanisms depend on the activation of BDNF/TrkB signaling.